Does SIROLIMUS Cause Basal cell carcinoma? 48 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Basal cell carcinoma have been filed in association with SIROLIMUS (sirolimus). This represents 0.4% of all adverse event reports for SIROLIMUS.
48
Reports of Basal cell carcinoma with SIROLIMUS
0.4%
of all SIROLIMUS reports
3
Deaths
6
Hospitalizations
How Dangerous Is Basal cell carcinoma From SIROLIMUS?
Of the 48 reports, 3 (6.3%) resulted in death, 6 (12.5%) required hospitalization, and 6 (12.5%) were considered life-threatening.
Is Basal cell carcinoma Listed in the Official Label?
Yes, Basal cell carcinoma is listed as a known adverse reaction in the official FDA drug label for SIROLIMUS.
What Other Side Effects Does SIROLIMUS Cause?
Off label use (1,960)
Drug ineffective (1,005)
Product use in unapproved indication (984)
Transplant rejection (698)
Pneumonia (599)
Product use issue (506)
Alopecia (491)
Acne (482)
Transplant dysfunction (468)
Condition aggravated (433)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which SIROLIMUS Alternatives Have Lower Basal cell carcinoma Risk?
SIROLIMUS vs SIRUKUMAB
SIROLIMUS vs SITAGLIPTIN
SIROLIMUS vs SOAP
SIROLIMUS vs SODIUM
SIROLIMUS vs SODIUM BICARBONATE